A total of 234 COVID-19 cases were identified among multiple sclerosis patients, of which 13.2% were hospitalized and 2.1% (5 patients) died due to the infection.

More information: Hannah E. Silverman et al, Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis, Neurology (2024). DOI: 10.1212/WNL ...

Engineered immunological niche directs therapeutic development in models of progressive multiple sclerosis. Proceedings of the National Academy of Sciences , 2025; 122 (7) DOI: 10.1073/pnas.2409852122 ...